Acadia Pharmaceuticals buy Royal Bank of Canada

Summary

This prediction ended on 15.07.24 with a price of €16.22. The BUY prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals performed very badly with a performance of -44.09%. Royal_Bank_of_Canada has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Royal_Bank_of_Canada has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
Acadia Pharmaceuticals	8.053%	8.053%	20.911%	-1.240%
iShares Core DAX®	2,57 %	3,50 %	8,41 %	62,27 %
iShares Nasdaq 100	4,86 %	0,65 %	28,38 %	85,45 %
iShares Nikkei 225®	5,59 %	-0,25 %	52,92 %	76,58 %
iShares S&P 500	3,25 %	2,08 %	24,37 %	68,71 %